| The conjugation of ubiquitin, a 76-amino-acid peptide, to a protein substrate provides a tag that either marks the labelled protein for degradation or modulates its function. The process of protein ubiquitylation -which is catalysed by coordinated enzymatic reactions that are mediated by enzymes known as E1, E2 and E3 -has an important role in the modulation of immune responses. Importantly, protein ubiquitylation is a reversible process, and removal of ubiquitin molecules is mediated by de-ubiquitylating enzymes: for example, A20, which has been implicated in the regulation of immune responses. In addition, the conjugation of ubiquitin-like molecules, such as ISG15 (interferon-stimulated protein of 15 kDa), to proteins is also involved in immune regulation. This Review covers recent progress in our understanding of protein ubiquitylation in the immune system.
The process of tagging the 76-amino-acid peptide ubiquitin to a protein substrate -known as protein ubiquitylation -was uncovered in the late 1970s and early 1980s and was implicated in the breakdown of harmful cellular proteins in an ATP-dependent manner 1 . This discovery of a non-lysosomal pathway of protein degradation led to Aaron Ciechanover, Avram Hershko and Irwin Rose being awarded the Nobel Prize in Chemistry for 2004. Following the initial, groundbreaking experiments, scientists then defined the cascade of reactions that mediates ubiquitin conjugation. This includes at least three steps (FIG. 1a) : first, the carboxy (C)-terminal glycine residue of ubiquitin is activated by a ubiquitin-activating enzyme, known as enzyme 1 (E1), resulting in the formation of a highenergy THIOESTER BOND between the glycine residue of ubiquitin and the cysteine residue of the active site of E1; second, the activated ubiquitin is transferred to the cysteine residue of the active site of a ubiquitinconjugating enzyme (known as E2); and third, the ubiquitin-E2 complex is recruited to a third enzyme, a ubiquitin-protein ligase (known as E3), which specifically binds a protein substrate and facilitates the transfer of ubiquitin from E2 to a lysine residue in the substrate 2, 3 .
E3 ligases can generally be classified into two families (FIG. 1b) : RING (really interesting new gene)type E3 ligases, and HECT (homologous to the E6-associated protein C terminus)-type E3 ligases. The family of RING-type E3 ligases can be further subdivided into two groups: single-protein E3 ligases, such as CBL (Casitas B-lineage lymphoma), in which the RING-finger domain and substrate-recruiting domains are found in one polypeptide; and multisubunit E3 ligases BOX 1. For example, SCF complexes (S-phase kinase-associated protein 1 (SKP1)-cullin-1 (CUL1)-F-box-protein complexes) are multisubunit E3 ligases in which the substrate-recruiting component, the FBOX PROTEIN, associates with the scaffold proteins SKP1 and CUL1 and with the RING-fingerdomain-only protein RBX1 (RING-box-1; also known as ROC1). In these complexes, RBX1 binds ubiquitinloaded E2, and the F-box protein specifically recruits the protein substrate and helps to transfer ubiquitin from E2 to the substrate. In both single-protein and multisubunit E3 ligases, the protein-recruiting domain or subunit is the crucial determinant of the specificity of the ubiquitylation process, which occurs through protein-protein interactions that are well defined at a biochemical level.
A substrate can be tagged with a single ubiquitin molecule, a process that is known as monoubiquitylation, or an elongated ubiquitin chain can be formed after the initial conjugation of a ubiquitin molecule, resulting in polyubiquitylation of the substrate 3 . Monoubiquitylation can occur on a single lysine residue or on several lysine residues in a substrate, leading to multiple monoubiquitylation. The ubiquitin molecules in a polyubiquitin chain are generally linked through the lysine residue at position 48 or 63 (and are known as K48-and K63-linked polyubiquitin chains, respectively); however, other lysine residues in a ubiquitin molecule have been shown to participate in linkage. Interestingly, the different types of polyubiquitin chain have different effects on the substrate. Although ubiquitin was originally proposed to deliver a 'kiss of death' , targeting the tagged protein to the cellular waste-disposal machinery (that is, the 26S proteasome), recent studies have shown that ubiquitylation of proteins has a broad impact on many cellular processes, including modification of protein function, facilitation of cell-surfacereceptor turnover and control of gene transcription 4 . For example, monoubiquitylation is involved in downmodulation of receptor expression through the endosomal-lysosomal pathway 5 , and K63-linked polyubiquitylation modulates protein-protein interactions 6 . By contrast, K48-linked polyubiquitylation targets substrates for proteasomal degradation.
In addition to ubiquitin, ubiquitin-like molecules, such as ISG15 (interferon (IFN)-stimulated protein of 15 kDa), also participate in similar conjugation reactions but with different functional outcomes. Importantly, analogous to protein phosphorylation and dephosphorylation processes, conjugation to ubiquitin or ISG15 is a reversible process, and substrate-linked ubiquitin and ISG15 molecules can be removed by de-ubiquitylating and de-ISGylating enzymes, respectively.
From the beginning, ubiquitin has been closely associated with the immune system, because it was originally identified as a lymphocyte-differentiationpromoting factor 7 . However, during the past few years, genetic and biochemical studies have provided evidence that protein ubiquitylation is of fundamental importance in the regulation of both the innate and the adaptive immune system, with roles in the control of immune tolerance, the differentiation of T cells, and the intracellular signal transduction that is induced by antigen, cytokines or Toll-like receptor (TLR) ligands. This Review discusses our current understanding of how conjugation to ubiquitin or the ubiquitin-like molecule ISG15, as well as de-conjugation by specific proteases, affects diverse immunological processes.
Ubiquitylation and immune tolerance
The immune system has evolved to mount robust responses to invading pathogens while not destroying (that is, being tolerant of ) self-tissues. T-cell tolerance to self-antigens is generated through both central and peripheral mechanisms 8, 9 . Central tolerance encompasses the processes by which T-cell recognition of self-antigen in the thymus renders the T cells tolerant to self-antigens; these processes Figure 1 | The ubiquitin-conjugation cycle and the E3 ligases. a | Ubiquitin is activated by a ubiquitin-activating enzyme (known as enzyme 1, E1) in the presence of ATP and becomes bound to this E1. The activated ubiquitin molecule is then transferred to a ubiquitin-conjugating enzyme (known as E2). Ubiquitin-protein ligases (known as E3 ligases) recruit both the ubiquitin-E2 complex and the substrate protein, and they help to transfer ubiquitin from E2 to the substrate. Substrate-conjugated ubiquitin is removed by de-ubiquitylating enzymes (DUBs). b | A schematic representation of several RING (really interesting new gene)-type and HECT (homologous to the E6-associated protein carboxy terminus)-type E3 ligases is shown. RINGtype E3 ligases can be divided into those that contain both the RING-finger domain and the substrate-recruiting domains (which are known as single-protein RING-type E3 ligases) and those that are multisubunit complexes composed of scaffold proteins, substrate-recruiting proteins and a RING-finger-domain-only protein. For example, suppressor of cytokine signalling (SOCS) proteins function as the substrate-recruiting component of the E3 ligase known as the ECS complex (elongin-B-elongin-C-cullin-5-SOCS-protein complex). A20 functions both as an E3 ligase -through its zinc finger (Zn) domain, which both recruits ubiquitin-E2 complexes and transfers the ubiquitin molecule to the substrate -and as a DUB, through its OTU (ovarian tumour) domain. For further details, see the main text. C2 domain, protein-kinase-C-related domain 2; CBL-B, Casitas B-lineage lymphoma B; GRAIL, gene related to anergy in lymphocytes; ITCH, itchy; PP i , pyrophosphate; ROQ domain, roquin domain; SH2 domain, SRChomology-2 domain; TKB domain, protein-tyrosine-kinase-binding domain; TRAF, tumournecrosis-factor-receptor-associated factor; WW domain, domain that contains two conserved tryptophan residues.
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THIOESTER BOND
A high-energy chemical bridge, such as that between ubiquitin and the active-site cysteine residue of E1. This chemical linkage is initially catalysed by adenylation of the glycine residue at the carboxy terminus of ubiquitin, through the hydrolysis of ATP, and then by linkage of this adenylated residue to the thiol group of the active-site cysteine residue of E1. The activated ubiquitin molecule is then transferred to E2, to which it is attached by a similar thioester bond.
FBOX PROTEIN
The F box is a protein module of ∼50 amino acids that interacts with SKP1 (S-phase kinase-associated protein 1) to form an SCF complex (SKP1-cullin-1-F-box-protein complex), which is an E3 ligase. F-box-containing proteins also have protein-interacting domains for recruiting the substrate protein.
include clonal deletion and the generation of CD4 + CD25 + REGULATORY T T Reg  CELLS. By contrast, peripheral tolerance encompasses the mechanisms that lead to T-cell tolerance if a T cell first encounters self-antigen outside the thymus; these include ignorance, deletion and anergy induction.
Central tolerance. It has been shown that a wide range of peripheral-tissue antigens -such as insulin, thyroglobulin and myelin proteolipid protein -are promiscuously expressed by medullary thymic epithelial cells (mTECs). Thymocytes encountering these antigens at the surface of mTECs are then subject to central-tolerance mechanisms and become tolerant to those antigens 10 . Genetic studies of a rare human autoimmune disease known as AUTOIMMUNE POLYENDOCRINOPATHYCANDIDIASISECTODERMALDYSTROPHY SYNDROME (APECED) underscore the importance of central tolerance 11, 12 . The gene that is responsible for APECED has been identified as the autoimmune regulator gene (AIRE), and more than 50 linked mutations have been mapped in human patients. AIRE is highly expressed in the thymus, particularly by mTECs 13 . Targeting of the Aire gene in mice causes the development of spontaneous multi-organ autoimmunity, similar to that of human patients with APECED 14, 15 . Notably, the expression of peripheraltissue-specific proteins such as prepro-insulin and cytochrome p450, which are known targets of autoreactive T cells in human patients with APECED, is decreased in AIRE-deficient mTECs in mice 14 . Deficiency in AIRE, however, did not change the number of thymocytes, the proportion of thymocytes that constitute particular subsets or the activation status of thymocytes, indicating that AIRE does not affect thymocyte development. So, AIRE seems to have an important role in central tolerance through regulating the promiscuous expression of peripheral-tissue self-antigens by mTECs (FIG. 2a) . DNA-microarray analysis further indicates that AIRE affects the expression by mTECs of genes that encode molecules involved in intrathymic cell migration, such as MHC molecules and certain chemokines 16 .
AIRE is a 58 kDa protein that, as well as other domains, contains two plant homeodomains (PHDs), which are related to RING-finger domains. AIRE is structurally related to the SP100 SPECKLED PROTEIN OF 100 kDa FAMILY OF TRANSCRIPTIONAL COACTIVATORS, and consistent with this, AIRE contains a nuclear-localization signal and translocates to the nucleus 17, 18 . PHDs have been identified in many proteins, some of which have been shown to have E3-ligase activity. For example, PHD-containing viral proteins are involved in downmodulation of the expression of cell-surface MHC or co-stimulatory molecules 19 . In vitro biochemical studies have shown that the PHDs of AIRE have E3-ligase activity, and this is abolished by mutation of the conserved cysteine residue in these RING-finger-like motifs 20 . The transactivating activity of AIRE also depends on the functionality of the PHDs. This indicates that AIRE might regulate central tolerance through its E3-ligase activity. But how this E3-ligase activity is coupled to regulation of gene transcription is still unclear. Furthermore, that AIRE has E3-ligase activity is disputed by an independent research group 21 .
During thymic selection, strong recognition of self-antigen by T cells (that is, with high affinity or high avidity) might trigger the apoptotic pathway and, subsequently, cause cell death 22 . By contrast, weak engagement of antigen (that is, with low affinity or low avidity) might not be able to trigger survival signals, resulting in death by neglect 23 . Only T cells that receive signals that engage the survival pathway but do not trigger apoptosis are positively selected and enter the peripheral T-cell pool. Two key regulators in promoting thymic negative selection are the orphan nuclear receptor NUR77 and the pro-apoptotic protein BIM (B-cell lymphoma 2 (BCL-2)-interacting mediator of cell death) 24, 25 . Loss of BIM results in thymocyte resistance to CD3-specific-antibody-induced cell death and to T-cell receptor (TCR)-mediated negative selection 25 . In a different cell system, BIM was found to be a substrate for CBL 26 , a well-characterized RINGtype E3 ligase that is implicated in diverse signalling pathways 27 .
CBL is a 120 kDa protein that, as well as other domains, contains a RING-finger domain. There are three mammalian CBL homologues: CBL, CBL-B and CBL3 (also known as CBL-C) 27 . CBL functions both as an adaptor molecule, forming complexes with several crucial signalling molecules, and as an E3 ligase, promoting the conjugation of ubiquitin to its binding partners. So far, several proteins have been found to be ubiquitylated by the E3-ligase activity of
Box 1 | Multisubunit RING-type E3 ligases
Members of the multisubunit RING (really interesting new gene)-type E3 ligase subfamily of E3 ligases consist of several subunits, with a RING-finger-domainonly protein (RING-box-1 (RBX1) or RBX2)
as the catalytic core that recruits a ubiquitin-E2 complex. RBX proteins associate with one of the five members of the cullin (CUL) family of scaffold proteins (CUL1, CUL2, CUL3, CUL4 and CUL5). The adaptor protein SKP1 (S-phase kinase-associated protein 1) bridges CUL1 with an F-box protein, which binds the protein substrate for ubiquitylation to form an SCF complex (SKP1-CUL1-F-box-protein complex). By contrast, the adaptor complex elongin-B-elongin-C associates with CUL5 and a SOCS (suppressor of cytokine signalling) protein, which recruits the protein substrate, to form an ECS complex (elongin-B-elongin-C-CUL5-SOCS-protein complex). In both types of multisubunit E3 ligase, the substrate-binding protein (that is, the F-box protein or the SOCS protein) determines the substrate specificity of the ubiquitylation process, which occurs, in most cases, by protein-protein interactions that are chemically well defined.
One of the best-characterized SCF complexes is SCF β-TRCP , in which the F-boxcontaining subunit is β-transducin repeat-containing protein (β-TRCP). The WD40 repeats in β-TRCP enable it to bind phosphorylated IκB (inhibitor of nuclear factor-κB, NF-κB). SCF β-TRCP induces polyubiquitylation and, subsequently, degradation of IκB. This is an essential step for the release of NF-κB from the Ub CUL (cullin). Cullin-family proteins (CUL1, CUL2, CUL3, CUL4 and CUL5) directly interact with the RING (really interesting new gene)-fingerdomain-only protein RBX1 (RING-box-1). The CUL-RBX1 complex is the core module of a series of multisubunit E3 ligases.
IκB-NF-κB complex, and it leads to the nuclear translocation and transcriptional activation of NF-κB. SOCS1 is a subunit of an ECS complex, and it binds Janus kinases (JAKs) through its SRC homology 2 (SH2) domain and the phosphorylated tyrosine residues of the
CD4 + CD25 + REGULATORY T CELL (T Reg cell). A specialized type of CD4 + T cell that can suppress the responses of other T cells. These cells provide a crucial mechanism for the maintenance of peripheral self-tolerance, and they are characterized by the expression of CD25 (also known as the α-chain of the interleukin-2 receptor) and the transcription factor forkhead box P3 (FOXP3). AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASISECTODERMAL DYSTROPHY SYNDROME (APECED). A rare human autoimmune disorder that is inherited in an autosomal recessive manner and is characterized by various endocrine deficiencies, chronic mucocutaneous candidiasis and several ectodermal dystrophies. It is caused by multiple mutations in the gene that encodes autoimmune regulator (AIRE).
SP100 FAMILY OF
TRANSCRIPTIONAL COACTIVATORS
The nuclear-matrix-associated protein SP100 (speckled protein of 100 kDa) belongs to a family of related proteins that contain nuclear-localization signals, dimerization domains and DNA-binding domains. They interact with other transcription factors to co-activate gene transcription. IONOMYCIN A divalent calcium ionophore that is widely used as a tool to investigate the role of intracellular calcium in cellular processes. COMPLETE FREUND'S ADJUVANT (CFA). A mixture of mycobacterial lysate and mineral oil. When animals are immunized with antigen emulsified in CFA, they induce strong immune responses to the antigen. CBL, including the ζ-chain of CD3 (CD3ζ), CRKL and SRC-family kinases 4 . Of relevance to thymocyte development, thymocytes from Cbl -/mice show increased signalling through the TCR 28, 29 . Cbl -/thymo cytes also show increased adhesion to intercellular adhesion molecule 1 (ICAM1), probably through increased association between CRKL and C3G (a guanine-nucleotide-exchange factor) and the subsequent activation of RAP1 (a member of the RAS family of small GTPases) 30 . However, whether CBL functions as an E3 ligase for BIM, or for other molecules that are involved in thymic selection, remains to be investigated.
T-cell anergy. For T cells, anergy is a form of peripheral
tolerance that is characterized by a lack of proliferation and interleukin-2 (IL-2) production by T cells, even after they have been appropriately stimulated 31 . It has been known for some time that, during anergy induction, TCR ligation in the absence of co-stimulation results in a block in mobilization of calcium ions (Ca 2+ ), as well as defective activation of RAS and, downstream, impaired phosphorylation of extracellular-signalregulated kinase (ERK) [32] [33] [34] . Recent studies, however, have provided molecular insights that improve our biochemical understanding of T-cell anergy induction. Treatment with IONOMYCIN or TCR ligation in the absence of co-stimulation leads to upregulation of expression of several E3 ligases, including CBL-B, itchy (ITCH) and gene related to anergy in lymphocytes (GRAIL) [35] [36] [37] . These E3 ligases downmodulate the function of phospholipase C-γ1 (PLC-γ1) and protein kinase C-θ (PKC-θ), signalling molecules that are crucial for T-cell activation; therefore, this blocks activation of downstream signalling pathways that are essential for IL-2 production and T-cell proliferation 36 (FIG. 2b) . Although all three of these E3 ligases are implicated in T-cell anergy induction in vitro, only CBL-B has been examined in vivo.
That CBL-B has a crucial role in T-cell anergy induction was further established using several in vivo mouse models, including adoptive transfer of pre-anergized CD4 + T cells, induction of anergy in viral-peptidespecific CD8 + T cells and induction of anergy using superantigen 37 . In each case, the anergized state of wildtype T cells that is induced by injection of antigen does not occur for CBL-B-deficient T cells. Furthermore, in a mouse model of autoimmune arthritis (in which disease is induced by immunization with type II collagen and COMPLETE FREUND'S ADJUVANT), it was shown A disease that is characterized by autoantibody production and nephritis and is caused by immune responses to selfproteins.
N-ETHYLN-NITROSOUREA
INDUCED MUTANT MOUSE
(ENU-induced mutant mouse). ENU is a highly potent mutagen that usually induces single base changes in DNA and is used for efficient large-scale insertional mutagenesis in mice (also known as forward genetic screening).
FOLLICULAR B HELPER T CELL
A type of T helper cell that provides help to B cells and is located in the B-cell areas of secondary lymphoid tissues. These cells express the chemokine receptor CXC-chemokine receptor 5 (CXCR5).
AGOUTI LOCUS
The agouti locus on mouse chromosome 2 determines the coat colour of a mouse by regulating the synthesis of yellow pigment by hair melanocytes. Mutations in this locus are also linked to the development of obesity and neoplasms.
WW DOMAIN
A protein-protein interaction module that contains two conserved tryptophan (W) residues ∼20-22 amino acids apart. This domain interacts with proline-rich motifs.
that Cblb -/mice develop disease even in the absence of administration of complete Freund's adjuvant, indicating that loss of CBL-B uncouples autoaggressive T-cell responses from innate immune signals. More strikingly, in a viral-peptide-induced tolerance model, Cblb -/mice were found to die quickly following a second injection of antigen, even though wild-type mice survived. So, CBL-B-mediated immune tolerance determines life and death, as a result of a lack of T-cell tolerance, following repeated challenge with antigen.
Analysis of naive Cblb -/-T cells has shown that the signalling molecules in these cells seem to be modified differently from those found in naive wild-type T cells. For example, it has previously been shown that, in freshly isolated Cblb -/-T cells, tyrosine phosphorylation of VAV1 and activation of AKT occur to a greater extent than in naive wild-type T cells [38] [39] [40] . Furthermore, the p85 subunit of phosphatidylinositol 3-kinase was identified as a substrate for CBL-B-mediated ubiquitylation in naive T cells 40 . By contrast, during anergy induction of wild-type T cells, CBL-B activity seems to lead mainly to decreased phosphorylation of PLC-γ1, resulting in decreased Ca 2+ mobilization 37 . More importantly, such a biochemical defect in antigen-receptorinduced Ca 2+ signalling was restored, to a large degree, by ablation of CBL-B 37 . These results indicate that there are both qualitative and quantitative differences in the signal-transduction pathways in naive and tolerized T cells and that these are, in part, because CBL-B has distinct targets in these two groups of cells.
It should be noted that the authors of two recent publications about E3 ligases and T-cell anergy came to distinct conclusions about how CBL-B might regulate PLC-γ1, and Ca 2+ flux, in anergic T cells: one concluded that CBL-B-mediated ubiquitylation induced the degradation of PLC-γ1 REF. 36, and the other concluded that CBL-B-mediated ubiquitylation reduced phosphorylation and therefore the activity of PLC-γ1 REF. 37. This discrepancy might reflect the different time points that were examined in the two studies: at earlier time points of restimulation, anergic T cells might only show modified PLC-γ1 phosphorylation 37 ; by contrast, at later time points, effects on PLC-γ1 degradation might become evident 36 . Because early signal transduction is crucial for determining whether T-cell recognition of antigen induces proliferation and IL-2 production, early attenuation of PLC-γ1 phosphorylation could be an essential step for T-cell anergy induction. Whether CBL-B-regulated PLC-γ1 degradation has a role in T-cell anergy induction needs to be established using Cblb mutants that lack E3-ligase activity. Moreover, PLC-γ1 is unlikely to be the only target molecule for the E3-ligase activity of CBL-B in anergic T cells. To gain a clear answer, more-comprehensive proteomics approaches need to be used to identify specific substrates of particular ligases.
Roquin as a repressor of autoimmunity.
The importance of E3 ligases in immune tolerance is further underscored by the recent identification of roquin. Roquin is an E3 ligase, the mutation of which in mice is linked to a severe SYSTEMICLUPUSERYTHEMATOSUS SLELIKE AUTOIMMUNE DISEASE 41 . Systematic screening of NETHYLNNITROSOUREAINDUCED MUTANT MICE led to the identification of a mutant mouse line that had an autoimmune phenotype similar to SLE: that is, high levels of autoantibody production, and nephritis with IgG deposition. The mutation causes intrinsic T-cell dysregulation, including increased numbers of FOLLICULAR B HELPER T CELLS with augmented inducible T-cell co-stimulator (ICOS) expression and IL-21 production. The mutation was mapped to a novel gene and was found to be a T to G point mutation that results in a methionine to arginine amino-acid substitution. The encoded protein, which is known as roquin, contains an amino (N)-terminal RING-finger domain followed by a unique ROQ domain and an RNA-binding zincfinger domain, as well as several other domains. It seems that roquin belongs to a large family of proteins that are highly conserved from invertebrates to humans and have as-yet-unknown functions. Interestingly, the N-terminal RING-finger domain is similar to the RING-finger domain of CBL and of TRAFs (tumournecrosis factor (TNF) receptor (TNFR)-associated factors), indicating that roquin functions as a RING-type E3 ligase. Roquin is localized in the cytoplasm (with a distinct dot-like appearance) together with T-cellinduced antigen 1, a translational silencing factor that is a component of cytoplasmic stress granules, which are implicated in the regulation of mRNA translation and stability 42 . This colocalization implies that roquin might function as a regulator of mRNA stability and/or translation. It should be noted that the point mutation that was identified in the mutant mice occurs in the ROQ domain, leading the authors to speculate that this mutation might alter the structure of roquin and therefore affect its biological function. However, whether this particular mutation affects the E3-ligase activity or the function of the RNA-binding zinc-finger domain awaits further investigation. Furthermore, the role of roquin in immune tolerance would be explained by identification of the substrate for its E3-ligase activity, which is unknown at present.
ITCH in T-cell differentiation
Genetic studies of the AGOUTI LOCUS and mouse coatcolour alterations uncovered an unusual mutation that causes immunological defects, as well as skin-and ear-scratching (itchy) phenotypes 43 . The itchy locus, which is disrupted in these mice, encodes a HECTtype E3 ligase known as ITCH, which consists of a C-terminal C2 domain (PKC-related domain 2), four WW DOMAINS and a C-terminal HECT-ligase domain 44 . Although the mutant mice have enlarged spleens and lymph nodes, in vitro studies showed that mutant T cells proliferate and produce IL-2 relatively normally after TCR ligation 45 mutant mice. The WW domains in ITCH bind PPXY motifs (where X denotes any amino acid) in the JUN PROTEINS JUN and JUNB (but not JUND), and ITCH has been shown to promote degradation of these transcription factors 45 . Indeed, the amount of JUNB protein is increased in Itch -/-T cells. This could be of importance, because T cells from transgenic mice that overexpress JUNB produce more T H 2 cytokines than T cells from wild-type animals 46 , whereas ablation of JUNB diminishes IL-4 and IL-5 secretion and impairs allergen-induced airway inflammation 47 .
Interestingly, T cells that express a kinase-domain deletion mutant of MEKK1 (mitogen-activated protein kinase (MAPK)/ERK kinase kinase 1) showed similar upregulation of T H 2-cytokine production 48 . Similar to Itch -/-T cells, this mutation in MEKK1 resulted in increased concentrations of JUN and JUNB, but not JUND, in T cells. In addition, the concentrations of other transcription factors that are important for the differentiation of CD4 + T cells into T H 2 cells, such as nuclear factor of activated T cells 1 (NFAT1; also known as NFATc2), GATA-binding protein 3 (GATA3) and MAF, were reported to be normal. Subsequent biochemical studies showed that MEKK1 functions upstream of ITCH activation, with JUN N-terminal kinase (JNK) functioning downstream of MEKK1 to effect phosphorylation of ITCH and, most importantly, upregulation of its E3-ligase activity 48 . This defines a signalling cascade that is initiated by TCR ligation and depends on MEKK1, and that results in JNK activation, ITCH phosphorylation and activation, and JUNB degradation. This cascade has a crucial role in modulating the differentiation of CD4 + T cells into T H 2 cells (FIG. 3) . In fact, ITCH is the first HECT-type E3 ligase (but probably not the only one) that has been found to have its catalytic activity directly regulated by its phosphorylation. Consistent with this model, studies using mice that are deficient in JNK or MAPK kinase 7 (MAPKK7), a kinase that relays MEKK1 activation to JNK, showed similar phenotypes: that is, T cells that lack either JNK or MAPKK7 produce more T H 2 cytokines than wildtype T cells 49 . Therefore, at least in T cells, contrary to the commonly held idea that the MEKK1-JNKmediated phosphorylation of JUN-family proteins is the main pathway that controls downstream gene transcription, the control of JUN-protein turnover through phosphorylation of an E3 ligase (that is, ITCH) seems more pertinent to the biological functions of MEKK1 and JNK.
Another conclusion from this study is that E3ligase-dependent ubiquitylation of a particular substrate is subject to complex regulation. Although the phosphorylation-dependent recognition of particular substrates by E3 ligases has been well studied 50 , MEKK1-JNK-induced phosphorylation of ITCH (and the subsequent activation of ITCH) is a novel example of regulation of protein turnover at the level of an E3 ligase, and phosphorylation of the substrates of ITCH (JUN and JUNB) seems to be irrelevant for their degradation 48 .
It has been argued that the strength of the signal that is received by a CD4 + T cell during antigen recognition regulates its development into a particular type of T H cell, with a weak signal leading to differentiation into T H 2 cells and a strong signal favouring development into T H 1 cells 51 . However, the underlying molecular mechanisms have remained largely unexplored. The proposed function of the MEKK1-JNK-ITCH cascade in differentiation into T H 2 cells might shed light on this long-standing paradox. It can be speculated that, when T cells receive a weak signal, the MEKK1-JNK pathway, which requires a strong co-stimulatory signal 52 , is not initiated, so T cells express large amounts of JUNB, which directs T H 2-cytokine production. By contrast, when T cells are strongly activated, the MEKK1-JNKsignalling pathway is switched on; this results in the phosphorylation and activation of ITCH, which leads to the turnover and degradation of JUN proteins and therefore to the dampening of differentiation into T H 2 cells. However, this attractive hypothesis needs to be tested: for example, by using mice transgenic for TCRs with varying affinities for peptide-MHC complexes.
Given the crucial role for JUN proteins in diverse biological functions, it is not surprising that ITCH is not the only E3 ligase that is involved in the ubiquitylation of JUN proteins. A human homologue of the Arabidopsis thaliana protein de-etiolated 1 (DET1) has been shown to associate with CUL4A and RBX1 to form a multisubunit E3 ligase that can promote ubiquitylation and degradation of JUN in a cell line 53 . In addition, in neurons, the stability of JUN is regulated by an SCF complex that contains the F-box protein FBW7 REF. 54. In this case, JUN needs to be phosphorylated to be recognized by FBW7, before it can be ubiquitylated and degraded. Whether these multisubunit E3-ligase components also have a role in immune regulation and T-cell tolerance remains to be investigated.
Ubiquitylation and nuclear factor-κB signalling
Differential ubiquitin-chain formation. Activation of the transcription factor nuclear factor-κB (NF-κB) is a centrepiece of innate immunity, because it is initiated in response to ligation of TLRs by pathogen-associated molecular patterns (PAMPs) 55 . NF-κB activation is also important for adaptive immunity and is one of the first immune responses that was found to depend on protein ubiquitylation 50 . The ligation of TLRs by PAMPs, as well as numerous other stimuli, causes phosphory lation of the NF-κB-bound molecule IκB (inhibitor of NF-κB), which is recognized by the F-box protein β-transducin repeat-containing protein (β-TRCP), a component of an SCF complex 50 BOX 1. IκB is poly ubiquitylated with a K48-linked polyubiquitin chain and is therefore targeted for proteasome-dependent degradation. This results in the liberation of IκB-bound NF-κB dimers, leading to their translocation to the nucleus and the transactivation of NF-κB target genes (FIG. 4) .
Phosphorylation of IκB is mediated by the IκB kinase (IKK) complex, which consists of three subunits: IKK-α, IKK-β and IKK-γ (also known as NEMO) 56 . Recent studies have shown that ubiquitylation is also crucical for activation of the IKK complex. Studies of TNFR and IL-1-receptor signalling led to the discovery that TRAFs, a family of proteins that is characterized by the presence of a RING-finger domain and coiledcoil domains, are important mediators of signal transduction through TNFRs 57 . One TRAF-family member, TRAF6, recruits the ubiquitin-UBC13 (ubiquitinconjugating enzyme 13)-UEV1 UBIQUITINCONJUGATING ENZYME E2 VARIANT 1 complex through its RING-finger domain and promotes ubiquitin conjugation to itself or to IKK-γ 6, 58 . However, instead of inducing conventional K48-linked polyubiquitylation, TRAF6 induces the formation of a K63-linked polyubiquitin chain. Importantly, K63-linked polyubiquitylation of IKK-γ does not lead to proteasome-dependent degradation but somehow results in activation of the IKK complex and the subsequent phosphorylation of IκB 58 .
Both genetic and biochemical studies have indicated that a complex consisting of CARMA1 (caspaserecruitment domain (CARD)-membrane-associated guanylate kinase (MAGUK) protein 1), BCL-10 and MALT1 (mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1) has an essential role in antigen-receptor signalling that leads to NF-κB activation 59 . This complex interacts with TRAF6, which directly associates with BCL-10-MALT1 REF. 58. The BCL-10-MALT1 complex induces (UEVs). An E2 normally functions as a single polypeptide. It has a conserved active-site cysteine residue that forms a thioester bond with a ubiquitin molecule bound to an E1 and a domain for interacting with RING (really interesting new gene)-finger domains or HECT (homologous to the E6-associated protein carboxy terminus) domains. However, a UEV resembles an E2 but lacks the canonical cysteine residue. UEVs form a complex with a specific E2, ubiquitinconjugating enzyme 13 (UBC13), to facilitate K63 (Lys63)-linked polyubiquitinchain assembly.
OTU DOMAIN (ovarian-tumour domain). A domain that is found in a large family of proteins characterized by the presence of a putative catalytic triad of cysteine proteases. Several of these proteins are known to function as de-ubiquitylating enzymes. oligomerization of TRAF6 and activation of its E3-ligase activity. Strikingly, BCL-10-MALT1 alone can target IKK-γ for K63-linked polyubiquitylation, even in the absence of TRAF6 REF. 60. It has therefore been suggested that the formation of the BCL-10-MALT1 complex leads to a conformational change in the complex, which results in recruitment of ubiquitin-bound UBC13 as an E2. Because BCL-10 and MALT1 also form oligomeric complexes with IKK-γ, the binding of ubiquitin-UBC13 to a BCL-10-MALT1 complex allows the transfer of ubiquitin to IKK-γ for K63linked polyubiquitylation. Therefore, even without a physical RING-finger domain, the BCL-10-MALT1 complex can function as an E3 ligase. Consistent with these biochemical studies, loss of CARMA1, BCL-10 or MALT1 results in defective NF-κB activation in both T cells and B cells 61 .
TCR ligation has also been shown to induce the recruitment of PKC-θ to plasma-membrane lipid rafts and the activation of PKC-θ, and this has been implicated in NF-κB activation (as has the BCL-10-MALT1 complex) 62 . However, the exact mechanisms by which PKC-θ 'communicates' with the IKK complex and induces NF-κB activation have remained unclear. But a recent study has indicated that 3-phosphoinositidedependent protein kinase 1 (PDK1) phosphorylates PKC-θ and thereby allows PKC-θ to recruit the IKK complex to the plasma membrane 63 . PDK1 also functions as an adaptor that physically associates with CARMA1, which then recruits the BCL-10-MALT1 complex to lipid rafts, forming a super-complex that induces K63-linked polyubiquitylation of IKK-γ (mediated by the BCL-10-MALT1 and, probably, TRAF6 components).
De-ubiquitylation.
The pleiotropic cytokine TNF elicits a broad range of immune and inflammatory responses by inducing NF-κB activation. Unlike antigen-receptor signalling, which depends on tyrosine phosphorylation, the binding of TNF to TNFR induces the formation of a signalling complex that includes TRADD (TNFR-associated via death domain), RIP1 (receptor-interacting protein 1), TRAF2 and A20 REF. 64. Formation of this complex helps to recruit the IKK complex to the vicinity of the activated receptor, and it is required for activation of the IKK complex. Similar to TRAF6, TRAF2 functions as an E3 ligase and promotes K63-linked polyubiquitylation of molecules such as RIP1 REF. 65. It is conceivable that K63-linked RIP1 might facilitate downstream NF-κB signalling.
A20 was originally discovered as a TNF-inducible gene product, and it functions as an inhibitor of TNF-induced signalling 66 . Importantly, ablation of A20 results in augmented responsiveness to lipopolysaccharide and TNF by thymocytes and fibroblasts 67 . A20 -/mice develop multi-organ inflammation and die at a young age. Loss of A20 seems to result in increased kinase activity of IKK and in prolonged activation of NF-κB. Structurally, A20 is characterized by the presence of an OTU OVARIAN TUMOUR DOMAIN linked to multiple zinc-finger domains in the C-terminal portion of the protein. Database searches showed that the OTU domain is characteristic of a superfamily of otubains, a group of putative cysteine proteases 68, 69 . This family of proteins contains conserved ubiquitin-interacting and ubiquitin-associated motifs that are commonly found in de-ubiquitylating enzymes, indicating that these proteins function as de-ubiquitylating enzymes. Indeed, A20 was later found to be a de-ubiquitylating enzyme for K63-linked polyubiquitylated RIP1, thereby leading to termination of TNF-induced NF-κB signalling 70 . This is not the end of the story. A20 also functions as an E3 ligase and recruits one of the E2 proteins UBCH5A or UBCH7 using its C-terminal zinc-finger domains (which also mediate the transfer of ubiquitin from E2 to the substrate), to promote the ubiquity lation of RIP1 REF. 70. In this reaction, the polyubiquitin chain is K48-linked and targets RIP1 for proteasomal degradation. Importantly, A20-induced ubiquitylation of RIP1 occurs after its de-ubiquitylation. Therefore, A20 is a dual-function enzyme: first, it operates as a de-ubiquitylating enzyme, removing the K63-linked polyubiquitin chain from RIP1; and second, it operates as an E3 ligase, promoting K48-linked polyubiquitylation of RIP1 and thereby targeting it for degradation (FIG. 5) . By functioning as a 'double-edged sword' , A20 prevents the over-reaction of innate immune responses. It remains unclear, however, whether A20 removes and adds ubiquitin molecules on the same lysine residues of RIP1 or on different residues.
Further analysis, using A20 -/macrophages, indicates that A20 also has an important role in the regulation of TLR-signalling pathways, which result in a wide range of responses, including NF-κB activation and pro-inflammatory cytokine production 71 . Similar to TNFR signalling, TLRs recruit RIPs and TRAFs to the receptor complex 72 . It seems that A20 also removes K63-linked polyubiquitin chains from TRAF6, thereby terminating NF-κB activation that is induced by TLR ligation 71 . Because RIP1 is also an essential mediator of TLR-induced NF-κB activation 73 , A20 might also modulate RIP1 through de-ubiquitylation and ubiquitylation during innate immune responses.
A20 is not the only de-ubiquitylating enzyme that is implicated in NF-κB signalling. The cylindromatosis protein (CYLD) -a tumour-suppressor protein, the mutation of which is linked to benign tumours in humans -specifically removes K63-linked polyubiquitin chains from TRAFs and does not affect K48-linked polyubiquitin chains on IκB [74] [75] [76] . Unlike the OTUdomain-containing protein A20, CYLD contains a classical ubiquitin C-terminal hydrolase domain, which confers cysteine-specific protease activity for the cleavage of polyubiquitin chains. It is not yet clear whether CYLD is involved in immune regulation.
Ubiquitylation and other cytokines
Ubiquitylation in transforming-growth-factor-βmediated signalling. Transforming growth factor-β (TGF-β) is a multifunctional cytokine that is implicated in the regulation of various aspects of immune responses. Ablation of TGF-β or expression of a dominant-negative TGF-β receptor results in aberrant lymphocyte proliferation and multi-organ inflammation 77, 78 . TGF-β also has an important role in the inhibition of CD4 + T-cell differentiation into T H 1 and T H 2 cells, by reducing expression of T-bet and GATA3 or by inhibiting phosphorylation of the TEC-family kinase ITK (IL-2-inducible T-cell kinase) [79] [80] [81] . Recently, TGF-β has also been shown to convert naive CD4 + CD25 -T cells in the periphery into T Reg cells (which are CD4 + CD25 + ) through induction of expression of a crucial transcription factor, forkhead box P3 (FOXP3) 82 . Collectively, these results indicate that TGF-β is an important cytokine in immune homeostasis and tolerance induction. TGF-β-mediated signalling is initiated by binding of the cytokine to its receptors, which are heterodimeric transmembrane serine/threonine kinases, and this is followed by phosphorylation of a family of SMADs (mothers against decapentaplegic homologues), translocation to the nucleus by these proteins and sub sequent regulation of gene transcription 83 . SMADs can be divided into three groups: receptor-regulated SMADs (R-SMADs; such as SMAD2 or SMAD3), commonmediator SMADs (Co-SMADs; such as SMAD4) and inhibitory SMADs (I-SMADs; such as SMAD7). Many studies have documented that the SMAD-signalling pathway, which is highly conserved, is subjected to regulation by ubiquitylation. At least two factors that regulate the ubiquitylation of SMADs, SMAD ubiquity lation regulatory factor 1 (SMURF1) and SMURF2, have been characterized as HECT-type E3 ligases 84, 85 . Structurally, the WW domains of SMURFs bind PPXY motifs in some SMADs 84 . However, SMURFs can either inhibit responses to TGF-β by inducing the degradation of SMADs 86 or increase signalling in response to TGF-β by inducing the degradation of SKI-related novel protein N (SnoN), a transcriptional repressor of SMADs that works by forming an inhibitory SMURF-SMAD-SnoN complex 87 . In addition, SMURF2 can bind the I-SMAD SMAD7, which forms a complex with the TGF-β receptor, thereby targeting the TGF-β receptor for ubiquitylation and degradation 88 .
Given the similarity of the immunological phenotypes of Itch -/mice and TGF-β-deficient mice, and given that both ITCH and SMURFs are HECT-type E3 ligases, the role of ITCH in TGF-β-mediated signalling was assessed 89 . The TGF-β-induced arrest in growth of mouse embryonic fibroblasts was not found to occur in ITCH-deficient mice. Surprisingly, ITCH was not found to affect the protein stability of either SMADs or SnoN. Instead, ITCH bound SMAD2 and promoted its ubiquitylation. It seems that ubiquitylation of SMAD2 increases its TGF-βinduced phosphorylation: ITCH facilitates the formation of a complex between the TGF-β receptor and SMAD2 through ubiquitylation of SMAD2, leading to an increase in TGF-β-induced gene transcription. So, ITCH functions as a positive regulator of TGF-β-mediated signalling through proteolysisindependent ubiquitylation. Whether this function of ITCH has a role in immune regulation, such as in T-cell differentiation or T Reg -cell generation, awaits further investigation.
Suppressor of cytokine signalling proteins as E3 ligases.
Suppressor of cytokine signalling (SOCS) proteins comprise a well-characterized family of proteins that inhibit the Janus kinase (JAK)-signal transducer and activator of transcription (STAT)-signalling pathway. (poly I:C). A synthetic polymer that resembles the RNA of infectious viruses and is used to stimulate the production of interferon by the immune system through binding Toll-like receptor.
The SOCS family has eight closely related members -SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6, SOCS7 and cytokine-inducible SRC homology 2 (SH2)-containing protein (CIS) -and each contains an SH2 domain and a C-terminal SOCSBOX DOMAIN 90 . Expression of SOCS proteins is induced after stimulation with cytokine. The SH2 domains of SOCS proteins then associate with phosphorylated tyrosine residues in activated JAKs, and this attenuates the kinase activity of these JAKs. The importance of this family of proteins became further evident following studies of gene-targeted mice. Socs1 -/mice show neonatal lethality, severe lymphopaenia, upregulated lymphocyte apoptosis and multi-organ lymphocyte infiltration [91] [92] [93] . The hyper-responsiveness of Socs1 -/lymphocytes was attributed to heightened IFN-γ-mediated signalling, which results in augmented phosphorylation of STAT1.
In early biochemical studies, SOCS proteins were identified as binding partners for the complex that forms between elongin B and elongin C. This multi-protein complex is now known as an ECS complex (elongin-B-elongin-C-CUL5-SOCSprotein complex), and it is an E3 ligase 94, 95 . In these complexes, CUL5 functions as a scaffold that binds elongin-B-elongin-C, a SOCS protein (which directly binds the substrate) and the RING-finger-domainonly protein RBX2 (which recruits ubiquitin-E2 complexes) (FIG. 6) . ECS complexes are analogous to SCF complexes, and together they form a subgroup of the multisubunit RING-type E3 ligases BOX 1. In the case of SCF complexes, the F-box protein recruits a specific protein substrate; by contrast, in the case of ECS complexes, the SOCS protein targets the ECS complex to a particular substrate and facilitates the transfer of ubiquitin from E2 to the substrate. Consistent with predictions from its structure, SOCS1 has been shown to promote the conjugation of ubiquitin to JAK2, VAV1 and the p65 subunit of NF-κB (also known as REL-A) [96] [97] [98] . Interestingly, it has been shown that, in genetically modified mice in which the SOCS-box domain of SOCS1 has been deleted, there are increased responses to IFN-γ, and such mice develop chronic multi-organ inflammation 99 . So, SOCS proteins are a crucial component of these multi-protein E3 ligases that bind a specific target and help to promote its ubiquitylation.
ISGylation and de-ISGylation
ISG15 was originally identified as an IFN-stimulated gene. This gene encodes a 15 kDa protein that has two ubiquitin-like domains 100, 101 . In addition to stimulation with type I IFNs, the expression of ISG15 is induced by microbial challenge, by genotoxic stress, during pregnancy and during retinoid-induced cellular differentiation. ISG15 is activated by an E1-like ubiquitin-activating enzyme (UBE1L) and is then transferred to UBCH8, which functions as an E2 for ISGylation of substrates 102, 103 . So far, several signalling molecules, including PLC-γ1, JAK1 and ERK, have been identified as substrates for ISG15 conjugation 104 . Because UBCH8 is also recruited to E3 ligases, it remains unclear whether the E3 ligases that function in ubiquitinconjugation pathways and ISG15-conjugation pathways are similar or distinct.
A recent exciting development is the identification of a de-ISGylating enzyme, ubiquitin-binding protein 43 (UBP43; also known as USP18). Biochemically, UBP43 functions as a protease that specifically removes ISG15 from the proteins to which it is conjugated 105 . However, ablation of Ubp43 in mice leads to hypersensitivity to POLYINOSINICPOLYCYTIDYLIC ACID (poly I:C), with reduced survival rates and decreased numbers of peripheral-blood cells and bone-marrow cells 106 . The JAK-STAT-signalling pathway is highly upregulated in Ubp43 -/cells following stimulation with type I IFNs, and this is accompanied by augmented cell death. In mouse models of viral infection, it was recently found that Ubp43 -/mice are highly resistant to lethal inoculation with lymphocytic choriomeningitis virus or vesicular stomatitis virus 107 . Viral replication in Ubp43 -/cells is abrogated, presumably as a result of the hyper-responsiveness to type I IFNs. This study shows the importance of a balance between ISGylation and de-ISGylation in the regulation of innate immune responses to viral infection. However, a more recent study showed that deficiency in ISG15 does not affect IFN-induced activation of STATs and immune responses to viral infection 108 . It should also be noted that UBP43 is itself regulated by ubiquitindependent degradation mediated by the multisubunit E3 ligase SCF SKP2 , in which SKP2 is the F-box protein that recruits the substrate 109 , indicating that there is another layer of control, which involves ISGylation, de-ISGylation and ubiquitylation. 
Concluding remarks
Various E3 ligases and de-conjugating enzymes have been identified as crucial regulators of immune responses. Mouse models of various diseases -such as autoimmune diabetes, arthritis, allergic asthma and viral infections -will provide important tools to study the biological significance of conjugating or de-conjugating molecules. In addition, comprehensive approaches such as proteomics and genomics are needed to identify the entire set of substrates that is recognized by a given ubiquitylating or de-ubiquitylating enzyme so that we can gain deeper insights into the mechanisms and specific targets by which ubiquitin-mediated or ubiquitin-like-molecule-mediated conjugation pathways participate in immune regulation. It is also anticipated that a better and more detailed understanding of the ubiquitin-conjugation system in immune regulation will ultimately help to develop novel therapeutic interventions for human diseases such as autoimmune diseases, cancer, allergic inflammation and infectious diseases.
